Vectura Ventures into Nebuliser Market with Activaero Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 3 (Table of Contents)
Published: 25 Mar-2014
DOI: 10.3833/pdr.v2014.i3.2016 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Furthering it ambition of becoming a speciality pharmaceutical company focused on respiratory diseases, UK-based pulmonary drug delivery company Vectura is to acquire Activaero in a deal worth up to €136 M (US$189 M)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS